- Home
- JDZG vs HCWB Comparison
JDZG vs HCWB Comparison
Compare JDZG & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JDZG
- HCWB
- Stock Information
- Founded
- JDZG 2020
- HCWB 2018
- Country
- JDZG China
- HCWB United States
- Employees
- JDZG N/A
- HCWB N/A
- Industry
- JDZG Other Consumer Services
- HCWB Biotechnology: Pharmaceutical Preparations
- Sector
- JDZG Real Estate
- HCWB Health Care
- Exchange
- JDZG Nasdaq
- HCWB Nasdaq
- Market Cap
- JDZG 29.3M
- HCWB 26.6M
- IPO Year
- JDZG 2024
- HCWB 2021
- Fundamental
- Price
- JDZG $0.62
- HCWB $0.77
- Analyst Decision
- JDZG
- HCWB
- Analyst Count
- JDZG 0
- HCWB 0
- Target Price
- JDZG N/A
- HCWB N/A
- AVG Volume (30 Days)
- JDZG 248.7K
- HCWB 28.7M
- Earning Date
- JDZG 12-03-2024
- HCWB 11-14-2024
- Dividend Yield
- JDZG N/A
- HCWB N/A
- EPS Growth
- JDZG N/A
- HCWB N/A
- EPS
- JDZG 0.06
- HCWB N/A
- Revenue
- JDZG $2,195,958.00
- HCWB $3,495,990.00
- Revenue This Year
- JDZG N/A
- HCWB N/A
- Revenue Next Year
- JDZG N/A
- HCWB N/A
- P/E Ratio
- JDZG $11.46
- HCWB N/A
- Revenue Growth
- JDZG 52.08
- HCWB 22.27
- 52 Week Low
- JDZG $0.45
- HCWB $0.28
- 52 Week High
- JDZG $15.08
- HCWB $2.52
- Technical
- Relative Strength Index (RSI)
- JDZG N/A
- HCWB 57.14
- Support Level
- JDZG N/A
- HCWB $0.28
- Resistance Level
- JDZG N/A
- HCWB $2.52
- Average True Range (ATR)
- JDZG 0.00
- HCWB 0.23
- MACD
- JDZG 0.00
- HCWB 0.05
- Stochastic Oscillator
- JDZG 0.00
- HCWB 22.01
About JDZG JIADE LIMITED Common stock
Jiade Ltd Ltd is engaged in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platforms and auxiliary solutions. The Group offers pre-enrollment guidance on school/selection and application development, training for entrance exams, and assistance in the application process. The Group also offers offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance in the People's Republic of China.
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.